{"id":"W2898236034","doi":"10.1093/annonc/mdy292.130","title":"Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR)","year":2018,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Osimertinib; Medicine; Gefitinib; T790M; Oncology; Internal medicine; Erlotinib; Randomized controlled trial; Progression-free survival; Lung cancer; Epidermal growth factor receptor; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001998086,0.001795995,0.00244003,0.0003155133,0.0005075976,0.001305847,0.001000575,0.002103196,0.01565683],"category_scores_gemma":[0.001891922,0.0006896579,0.001891742,0.0003952712,0.001269657,0.001436305,0.000586901,0.003995879,0.002485896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001168641,"about_ca_system_score_gemma":0.002196676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009827446,"about_ca_topic_score_gemma":0.003704899,"domain_scores_codex":[0.9993107,0.000319178,0.00003307958,0.000187303,0.0000512995,0.00009837407],"domain_scores_gemma":[0.9989216,0.0001803255,0.0002557997,0.0001033204,0.0001012136,0.0004376862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9759478,0.005888536,0.0005518502,0.0004930479,0.0007345411,0.00005144462,0.00004581972,0.0003259043,0.001681215,0.0002103127,0.003023253,0.01104626],"study_design_scores_gemma":[0.974299,0.02353831,0.0005227202,0.00002317935,0.0001667376,0.00003161336,0.00001147938,0.0002027881,0.0001167602,0.0001730269,0.0009074477,0.000006967446],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9393379,0.007236101,0.001781194,0.004973565,0.003262073,0.02525136,0.006092804,0.0004476101,0.01161747],"genre_scores_gemma":[0.9324941,0.004064011,0.004112702,0.007170718,0.001133718,0.02645629,0.006560608,0.00007776513,0.01793001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01565683,"threshold_uncertainty_score":0.05237728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07165732510328492,"score_gpt":0.4499715277299406,"score_spread":0.3783142026266557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}